id: alcohol_use_disorder_to_NEW:alcohol_associated_cirrhosis
name: Alcohol Use Disorder â†’ Alcohol-Associated Cirrhosis
from_node:
  node_id: alcohol_use_disorder
  node_name: Alcohol Use Disorder
to_node:
  node_id: NEW:alcohol_associated_cirrhosis
  node_name: Alcohol-Associated Cirrhosis
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Sustained heavy alcohol consumption in AUD leads to chronic hepatocyte injury'
- 'Step 2: Repeated cycles of injury and repair trigger hepatic stellate cell activation'
- 'Step 3: Activated stellate cells produce excessive collagen leading to progressive fibrosis'
- 'Step 4: End-stage fibrosis results in cirrhosis with architectural distortion and portal hypertension'
evidence:
  quality_rating: A
  n_studies: 35
  primary_citation: 'Sachin Amonker et al. 2023. "Prevalence of alcohol-associated liver disease: a systematic
    review and meta-analysis." https://doi.org/10.1097/HC9.0000000000000133'
  supporting_citations:
  - Additional citations require full-text access - meta-analysis included 502 cases of alcohol-associated
    cirrhosis
  - Studies included universal testing protocols across multiple healthcare settings
  - Primary care and general population studies provided baseline prevalence estimates
  doi: 10.1097/HC9.0000000000000133
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Among individuals with alcohol use disorder, 12.9% have alcohol-associated cirrhosis, compared
  to only 0.3% in general populations and 1.7% in primary care. This represents a severe progression of
  liver disease concentrated in the AUD population.
quantitative_effects:
  effect_size:
    value: 12.9
    type: percentage_change
    ci_lower: 4.3
    ci_upper: 33.2
  sample_size: 513278
moderators:
- name: healthcare_setting
  direction: strengthens
  strength: strong
  description: Cirrhosis prevalence is 12.9% in AUD populations vs 0.3% in general populations vs 1.7%
    in primary care - approximately 40-fold difference between general population and AUD settings
structural_competency:
  equity_implications: The concentration of cirrhosis in AUD populations highlights failures in early
    intervention and treatment access. Structural barriers to AUD treatment including stigma, lack of
    insurance coverage, limited treatment capacity, and inadequate screening in healthcare settings allow
    liver disease to progress to end-stage cirrhosis. Equity implications include differential access
    to transplantation and advanced care for marginalized populations.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.419520'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
